Report Details
Not found what are you looking for
Medical Care
Global Pharmaceutical CMO and CDMO Market Research Report 2024(Status and Outlook)
By Type : API CMO and CDMO, FDF CMO and CDMO, Packaging CMO, Clinical CDMO
By Application : Pharmaceutical Company, Biotechnology Company, Other
Description
ToC>
Tables & Figures
Companies
Speak with Analyst
Report Overview
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
This report provides a deep insight into the global Pharmaceutical CMO and CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmaceutical CMO and CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmaceutical CMO and CDMO market in any manner.
Global Pharmaceutical CMO and CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza
Catalent
Thermo Fisher Scientific
Samsung Biologics
Fareva
WuXi AppTech
WuXi Biologics
Siegfried
FUJIFILM Diosynth Biotechnologies
Asymchem
Pfizer CentreOne
Delpharm
Recipharm
AGC Pharma Chemicals
Boehringer Ingelheim
Vetter
Curia
Aenova
Porton
Piramal
Strides Pharma
NextPharma
Famar
Jubilant
Alcami
Euroapi
Eurofins
Avid Bioservices
BioVectra
CPL
Market Segmentation (by Type)
API CMO and CDMO
FDF CMO and CDMO
Packaging CMO
Clinical CDMO
Market Segmentation (by Application)
Pharmaceutical Company
Biotechnology Company
Other
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Pharmaceutical CMO and CDMO Market
• Overview of the regional outlook of the Pharmaceutical CMO and CDMO Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmaceutical CMO and CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
FAQ
- You should buy this report from Xcellent Insights for a better clarity on market scenarios.
- The market report has been prepared using a pragmatic approach to suit your needs.
- We have an extensive library of reports that can help you understand the market landscape and make informed decisions about your business.
- Additionally, the reports are written by experienced analysts who have a deep understanding of the market and the latest trends.
- Besides, customization is a value-added service if you decide to opt.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pharmaceutical CMO and CDMO
1.2 Key Market Segments
1.2.1 Pharmaceutical CMO and CDMO Segment by Type
1.2.2 Pharmaceutical CMO and CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pharmaceutical CMO and CDMO Market Overview
2.1 Global Market Overview
2.1.1 Global Pharmaceutical CMO and CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmaceutical CMO and CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pharmaceutical CMO and CDMO Market Competitive Landscape
3.1 Global Pharmaceutical CMO and CDMO Sales by Manufacturers (2019-2024)
3.2 Global Pharmaceutical CMO and CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmaceutical CMO and CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmaceutical CMO and CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmaceutical CMO and CDMO Sales Sites, Area Served, Product Type
3.6 Pharmaceutical CMO and CDMO Market Competitive Situation and Trends
3.6.1 Pharmaceutical CMO and CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmaceutical CMO and CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pharmaceutical CMO and CDMO Industry Chain Analysis
4.1 Pharmaceutical CMO and CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pharmaceutical CMO and CDMO Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pharmaceutical CMO and CDMO Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmaceutical CMO and CDMO Sales Market Share by Type (2019-2024)
6.3 Global Pharmaceutical CMO and CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Pharmaceutical CMO and CDMO Price by Type (2019-2024)
7 Pharmaceutical CMO and CDMO Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmaceutical CMO and CDMO Market Sales by Application (2019-2024)
7.3 Global Pharmaceutical CMO and CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmaceutical CMO and CDMO Sales Growth Rate by Application (2019-2024)
8 Pharmaceutical CMO and CDMO Market Segmentation by Region
8.1 Global Pharmaceutical CMO and CDMO Sales by Region
8.1.1 Global Pharmaceutical CMO and CDMO Sales by Region
8.1.2 Global Pharmaceutical CMO and CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmaceutical CMO and CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmaceutical CMO and CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmaceutical CMO and CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmaceutical CMO and CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmaceutical CMO and CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Lonza
9.1.1 Lonza Pharmaceutical CMO and CDMO Basic Information
9.1.2 Lonza Pharmaceutical CMO and CDMO Product Overview
9.1.3 Lonza Pharmaceutical CMO and CDMO Product Market Performance
9.1.4 Lonza Business Overview
9.1.5 Lonza Pharmaceutical CMO and CDMO SWOT Analysis
9.1.6 Lonza Recent Developments
9.2 Catalent
9.2.1 Catalent Pharmaceutical CMO and CDMO Basic Information
9.2.2 Catalent Pharmaceutical CMO and CDMO Product Overview
9.2.3 Catalent Pharmaceutical CMO and CDMO Product Market Performance
9.2.4 Catalent Business Overview
9.2.5 Catalent Pharmaceutical CMO and CDMO SWOT Analysis
9.2.6 Catalent Recent Developments
9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Pharmaceutical CMO and CDMO Basic Information
9.3.2 Thermo Fisher Scientific Pharmaceutical CMO and CDMO Product Overview
9.3.3 Thermo Fisher Scientific Pharmaceutical CMO and CDMO Product Market Performance
9.3.4 Thermo Fisher Scientific Pharmaceutical CMO and CDMO SWOT Analysis
9.3.5 Thermo Fisher Scientific Business Overview
9.3.6 Thermo Fisher Scientific Recent Developments
9.4 Samsung Biologics
9.4.1 Samsung Biologics Pharmaceutical CMO and CDMO Basic Information
9.4.2 Samsung Biologics Pharmaceutical CMO and CDMO Product Overview
9.4.3 Samsung Biologics Pharmaceutical CMO and CDMO Product Market Performance
9.4.4 Samsung Biologics Business Overview
9.4.5 Samsung Biologics Recent Developments
9.5 Fareva
9.5.1 Fareva Pharmaceutical CMO and CDMO Basic Information
9.5.2 Fareva Pharmaceutical CMO and CDMO Product Overview
9.5.3 Fareva Pharmaceutical CMO and CDMO Product Market Performance
9.5.4 Fareva Business Overview
9.5.5 Fareva Recent Developments
9.6 WuXi AppTech
9.6.1 WuXi AppTech Pharmaceutical CMO and CDMO Basic Information
9.6.2 WuXi AppTech Pharmaceutical CMO and CDMO Product Overview
9.6.3 WuXi AppTech Pharmaceutical CMO and CDMO Product Market Performance
9.6.4 WuXi AppTech Business Overview
9.6.5 WuXi AppTech Recent Developments
9.7 WuXi Biologics
9.7.1 WuXi Biologics Pharmaceutical CMO and CDMO Basic Information
9.7.2 WuXi Biologics Pharmaceutical CMO and CDMO Product Overview
9.7.3 WuXi Biologics Pharmaceutical CMO and CDMO Product Market Performance
9.7.4 WuXi Biologics Business Overview
9.7.5 WuXi Biologics Recent Developments
9.8 Siegfried
9.8.1 Siegfried Pharmaceutical CMO and CDMO Basic Information
9.8.2 Siegfried Pharmaceutical CMO and CDMO Product Overview
9.8.3 Siegfried Pharmaceutical CMO and CDMO Product Market Performance
9.8.4 Siegfried Business Overview
9.8.5 Siegfried Recent Developments
9.9 FUJIFILM Diosynth Biotechnologies
9.9.1 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Basic Information
9.9.2 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Product Overview
9.9.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Product Market Performance
9.9.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.10 Asymchem
9.10.1 Asymchem Pharmaceutical CMO and CDMO Basic Information
9.10.2 Asymchem Pharmaceutical CMO and CDMO Product Overview
9.10.3 Asymchem Pharmaceutical CMO and CDMO Product Market Performance
9.10.4 Asymchem Business Overview
9.10.5 Asymchem Recent Developments
9.11 Pfizer CentreOne
9.11.1 Pfizer CentreOne Pharmaceutical CMO and CDMO Basic Information
9.11.2 Pfizer CentreOne Pharmaceutical CMO and CDMO Product Overview
9.11.3 Pfizer CentreOne Pharmaceutical CMO and CDMO Product Market Performance
9.11.4 Pfizer CentreOne Business Overview
9.11.5 Pfizer CentreOne Recent Developments
9.12 Delpharm
9.12.1 Delpharm Pharmaceutical CMO and CDMO Basic Information
9.12.2 Delpharm Pharmaceutical CMO and CDMO Product Overview
9.12.3 Delpharm Pharmaceutical CMO and CDMO Product Market Performance
9.12.4 Delpharm Business Overview
9.12.5 Delpharm Recent Developments
9.13 Recipharm
9.13.1 Recipharm Pharmaceutical CMO and CDMO Basic Information
9.13.2 Recipharm Pharmaceutical CMO and CDMO Product Overview
9.13.3 Recipharm Pharmaceutical CMO and CDMO Product Market Performance
9.13.4 Recipharm Business Overview
9.13.5 Recipharm Recent Developments
9.14 AGC Pharma Chemicals
9.14.1 AGC Pharma Chemicals Pharmaceutical CMO and CDMO Basic Information
9.14.2 AGC Pharma Chemicals Pharmaceutical CMO and CDMO Product Overview
9.14.3 AGC Pharma Chemicals Pharmaceutical CMO and CDMO Product Market Performance
9.14.4 AGC Pharma Chemicals Business Overview
9.14.5 AGC Pharma Chemicals Recent Developments
9.15 Boehringer Ingelheim
9.15.1 Boehringer Ingelheim Pharmaceutical CMO and CDMO Basic Information
9.15.2 Boehringer Ingelheim Pharmaceutical CMO and CDMO Product Overview
9.15.3 Boehringer Ingelheim Pharmaceutical CMO and CDMO Product Market Performance
9.15.4 Boehringer Ingelheim Business Overview
9.15.5 Boehringer Ingelheim Recent Developments
9.16 Vetter
9.16.1 Vetter Pharmaceutical CMO and CDMO Basic Information
9.16.2 Vetter Pharmaceutical CMO and CDMO Product Overview
9.16.3 Vetter Pharmaceutical CMO and CDMO Product Market Performance
9.16.4 Vetter Business Overview
9.16.5 Vetter Recent Developments
9.17 Curia
9.17.1 Curia Pharmaceutical CMO and CDMO Basic Information
9.17.2 Curia Pharmaceutical CMO and CDMO Product Overview
9.17.3 Curia Pharmaceutical CMO and CDMO Product Market Performance
9.17.4 Curia Business Overview
9.17.5 Curia Recent Developments
9.18 Aenova
9.18.1 Aenova Pharmaceutical CMO and CDMO Basic Information
9.18.2 Aenova Pharmaceutical CMO and CDMO Product Overview
9.18.3 Aenova Pharmaceutical CMO and CDMO Product Market Performance
9.18.4 Aenova Business Overview
9.18.5 Aenova Recent Developments
9.19 Porton
9.19.1 Porton Pharmaceutical CMO and CDMO Basic Information
9.19.2 Porton Pharmaceutical CMO and CDMO Product Overview
9.19.3 Porton Pharmaceutical CMO and CDMO Product Market Performance
9.19.4 Porton Business Overview
9.19.5 Porton Recent Developments
9.20 Piramal
9.20.1 Piramal Pharmaceutical CMO and CDMO Basic Information
9.20.2 Piramal Pharmaceutical CMO and CDMO Product Overview
9.20.3 Piramal Pharmaceutical CMO and CDMO Product Market Performance
9.20.4 Piramal Business Overview
9.20.5 Piramal Recent Developments
9.21 Strides Pharma
9.21.1 Strides Pharma Pharmaceutical CMO and CDMO Basic Information
9.21.2 Strides Pharma Pharmaceutical CMO and CDMO Product Overview
9.21.3 Strides Pharma Pharmaceutical CMO and CDMO Product Market Performance
9.21.4 Strides Pharma Business Overview
9.21.5 Strides Pharma Recent Developments
9.22 NextPharma
9.22.1 NextPharma Pharmaceutical CMO and CDMO Basic Information
9.22.2 NextPharma Pharmaceutical CMO and CDMO Product Overview
9.22.3 NextPharma Pharmaceutical CMO and CDMO Product Market Performance
9.22.4 NextPharma Business Overview
9.22.5 NextPharma Recent Developments
9.23 Famar
9.23.1 Famar Pharmaceutical CMO and CDMO Basic Information
9.23.2 Famar Pharmaceutical CMO and CDMO Product Overview
9.23.3 Famar Pharmaceutical CMO and CDMO Product Market Performance
9.23.4 Famar Business Overview
9.23.5 Famar Recent Developments
9.24 Jubilant
9.24.1 Jubilant Pharmaceutical CMO and CDMO Basic Information
9.24.2 Jubilant Pharmaceutical CMO and CDMO Product Overview
9.24.3 Jubilant Pharmaceutical CMO and CDMO Product Market Performance
9.24.4 Jubilant Business Overview
9.24.5 Jubilant Recent Developments
9.25 Alcami
9.25.1 Alcami Pharmaceutical CMO and CDMO Basic Information
9.25.2 Alcami Pharmaceutical CMO and CDMO Product Overview
9.25.3 Alcami Pharmaceutical CMO and CDMO Product Market Performance
9.25.4 Alcami Business Overview
9.25.5 Alcami Recent Developments
9.26 Euroapi
9.26.1 Euroapi Pharmaceutical CMO and CDMO Basic Information
9.26.2 Euroapi Pharmaceutical CMO and CDMO Product Overview
9.26.3 Euroapi Pharmaceutical CMO and CDMO Product Market Performance
9.26.4 Euroapi Business Overview
9.26.5 Euroapi Recent Developments
9.27 Eurofins
9.27.1 Eurofins Pharmaceutical CMO and CDMO Basic Information
9.27.2 Eurofins Pharmaceutical CMO and CDMO Product Overview
9.27.3 Eurofins Pharmaceutical CMO and CDMO Product Market Performance
9.27.4 Eurofins Business Overview
9.27.5 Eurofins Recent Developments
9.28 Avid Bioservices
9.28.1 Avid Bioservices Pharmaceutical CMO and CDMO Basic Information
9.28.2 Avid Bioservices Pharmaceutical CMO and CDMO Product Overview
9.28.3 Avid Bioservices Pharmaceutical CMO and CDMO Product Market Performance
9.28.4 Avid Bioservices Business Overview
9.28.5 Avid Bioservices Recent Developments
9.29 BioVectra
9.29.1 BioVectra Pharmaceutical CMO and CDMO Basic Information
9.29.2 BioVectra Pharmaceutical CMO and CDMO Product Overview
9.29.3 BioVectra Pharmaceutical CMO and CDMO Product Market Performance
9.29.4 BioVectra Business Overview
9.29.5 BioVectra Recent Developments
9.30 CPL
9.30.1 CPL Pharmaceutical CMO and CDMO Basic Information
9.30.2 CPL Pharmaceutical CMO and CDMO Product Overview
9.30.3 CPL Pharmaceutical CMO and CDMO Product Market Performance
9.30.4 CPL Business Overview
9.30.5 CPL Recent Developments
10 Pharmaceutical CMO and CDMO Market Forecast by Region
10.1 Global Pharmaceutical CMO and CDMO Market Size Forecast
10.2 Global Pharmaceutical CMO and CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmaceutical CMO and CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Pharmaceutical CMO and CDMO Market Size Forecast by Region
10.2.4 South America Pharmaceutical CMO and CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmaceutical CMO and CDMO by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pharmaceutical CMO and CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmaceutical CMO and CDMO by Type (2025-2030)
11.1.2 Global Pharmaceutical CMO and CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmaceutical CMO and CDMO by Type (2025-2030)
11.2 Global Pharmaceutical CMO and CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Pharmaceutical CMO and CDMO Sales (K Units) Forecast by Application
11.2.2 Global Pharmaceutical CMO and CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmaceutical CMO and CDMO Market Size Comparison by Region (M USD)
Table 5. Global Pharmaceutical CMO and CDMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Pharmaceutical CMO and CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pharmaceutical CMO and CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pharmaceutical CMO and CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CMO and CDMO as of 2022)
Table 10. Global Market Pharmaceutical CMO and CDMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pharmaceutical CMO and CDMO Sales Sites and Area Served
Table 12. Manufacturers Pharmaceutical CMO and CDMO Product Type
Table 13. Global Pharmaceutical CMO and CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharmaceutical CMO and CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmaceutical CMO and CDMO Market Challenges
Table 22. Global Pharmaceutical CMO and CDMO Sales by Type (K Units)
Table 23. Global Pharmaceutical CMO and CDMO Market Size by Type (M USD)
Table 24. Global Pharmaceutical CMO and CDMO Sales (K Units) by Type (2019-2024)
Table 25. Global Pharmaceutical CMO and CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Pharmaceutical CMO and CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Pharmaceutical CMO and CDMO Market Size Share by Type (2019-2024)
Table 28. Global Pharmaceutical CMO and CDMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Pharmaceutical CMO and CDMO Sales (K Units) by Application
Table 30. Global Pharmaceutical CMO and CDMO Market Size by Application
Table 31. Global Pharmaceutical CMO and CDMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Pharmaceutical CMO and CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Pharmaceutical CMO and CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Pharmaceutical CMO and CDMO Market Share by Application (2019-2024)
Table 35. Global Pharmaceutical CMO and CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Pharmaceutical CMO and CDMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Pharmaceutical CMO and CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Pharmaceutical CMO and CDMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Pharmaceutical CMO and CDMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Pharmaceutical CMO and CDMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Pharmaceutical CMO and CDMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Pharmaceutical CMO and CDMO Sales by Region (2019-2024) & (K Units)
Table 43. Lonza Pharmaceutical CMO and CDMO Basic Information
Table 44. Lonza Pharmaceutical CMO and CDMO Product Overview
Table 45. Lonza Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Lonza Business Overview
Table 47. Lonza Pharmaceutical CMO and CDMO SWOT Analysis
Table 48. Lonza Recent Developments
Table 49. Catalent Pharmaceutical CMO and CDMO Basic Information
Table 50. Catalent Pharmaceutical CMO and CDMO Product Overview
Table 51. Catalent Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Catalent Business Overview
Table 53. Catalent Pharmaceutical CMO and CDMO SWOT Analysis
Table 54. Catalent Recent Developments
Table 55. Thermo Fisher Scientific Pharmaceutical CMO and CDMO Basic Information
Table 56. Thermo Fisher Scientific Pharmaceutical CMO and CDMO Product Overview
Table 57. Thermo Fisher Scientific Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Thermo Fisher Scientific Pharmaceutical CMO and CDMO SWOT Analysis
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Recent Developments
Table 61. Samsung Biologics Pharmaceutical CMO and CDMO Basic Information
Table 62. Samsung Biologics Pharmaceutical CMO and CDMO Product Overview
Table 63. Samsung Biologics Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Samsung Biologics Business Overview
Table 65. Samsung Biologics Recent Developments
Table 66. Fareva Pharmaceutical CMO and CDMO Basic Information
Table 67. Fareva Pharmaceutical CMO and CDMO Product Overview
Table 68. Fareva Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Fareva Business Overview
Table 70. Fareva Recent Developments
Table 71. WuXi AppTech Pharmaceutical CMO and CDMO Basic Information
Table 72. WuXi AppTech Pharmaceutical CMO and CDMO Product Overview
Table 73. WuXi AppTech Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. WuXi AppTech Business Overview
Table 75. WuXi AppTech Recent Developments
Table 76. WuXi Biologics Pharmaceutical CMO and CDMO Basic Information
Table 77. WuXi Biologics Pharmaceutical CMO and CDMO Product Overview
Table 78. WuXi Biologics Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. WuXi Biologics Business Overview
Table 80. WuXi Biologics Recent Developments
Table 81. Siegfried Pharmaceutical CMO and CDMO Basic Information
Table 82. Siegfried Pharmaceutical CMO and CDMO Product Overview
Table 83. Siegfried Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Siegfried Business Overview
Table 85. Siegfried Recent Developments
Table 86. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Basic Information
Table 87. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Product Overview
Table 88. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. FUJIFILM Diosynth Biotechnologies Business Overview
Table 90. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 91. Asymchem Pharmaceutical CMO and CDMO Basic Information
Table 92. Asymchem Pharmaceutical CMO and CDMO Product Overview
Table 93. Asymchem Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Asymchem Business Overview
Table 95. Asymchem Recent Developments
Table 96. Pfizer CentreOne Pharmaceutical CMO and CDMO Basic Information
Table 97. Pfizer CentreOne Pharmaceutical CMO and CDMO Product Overview
Table 98. Pfizer CentreOne Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Pfizer CentreOne Business Overview
Table 100. Pfizer CentreOne Recent Developments
Table 101. Delpharm Pharmaceutical CMO and CDMO Basic Information
Table 102. Delpharm Pharmaceutical CMO and CDMO Product Overview
Table 103. Delpharm Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Delpharm Business Overview
Table 105. Delpharm Recent Developments
Table 106. Recipharm Pharmaceutical CMO and CDMO Basic Information
Table 107. Recipharm Pharmaceutical CMO and CDMO Product Overview
Table 108. Recipharm Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Recipharm Business Overview
Table 110. Recipharm Recent Developments
Table 111. AGC Pharma Chemicals Pharmaceutical CMO and CDMO Basic Information
Table 112. AGC Pharma Chemicals Pharmaceutical CMO and CDMO Product Overview
Table 113. AGC Pharma Chemicals Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. AGC Pharma Chemicals Business Overview
Table 115. AGC Pharma Chemicals Recent Developments
Table 116. Boehringer Ingelheim Pharmaceutical CMO and CDMO Basic Information
Table 117. Boehringer Ingelheim Pharmaceutical CMO and CDMO Product Overview
Table 118. Boehringer Ingelheim Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Boehringer Ingelheim Business Overview
Table 120. Boehringer Ingelheim Recent Developments
Table 121. Vetter Pharmaceutical CMO and CDMO Basic Information
Table 122. Vetter Pharmaceutical CMO and CDMO Product Overview
Table 123. Vetter Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Vetter Business Overview
Table 125. Vetter Recent Developments
Table 126. Curia Pharmaceutical CMO and CDMO Basic Information
Table 127. Curia Pharmaceutical CMO and CDMO Product Overview
Table 128. Curia Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Curia Business Overview
Table 130. Curia Recent Developments
Table 131. Aenova Pharmaceutical CMO and CDMO Basic Information
Table 132. Aenova Pharmaceutical CMO and CDMO Product Overview
Table 133. Aenova Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Aenova Business Overview
Table 135. Aenova Recent Developments
Table 136. Porton Pharmaceutical CMO and CDMO Basic Information
Table 137. Porton Pharmaceutical CMO and CDMO Product Overview
Table 138. Porton Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Porton Business Overview
Table 140. Porton Recent Developments
Table 141. Piramal Pharmaceutical CMO and CDMO Basic Information
Table 142. Piramal Pharmaceutical CMO and CDMO Product Overview
Table 143. Piramal Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Piramal Business Overview
Table 145. Piramal Recent Developments
Table 146. Strides Pharma Pharmaceutical CMO and CDMO Basic Information
Table 147. Strides Pharma Pharmaceutical CMO and CDMO Product Overview
Table 148. Strides Pharma Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Strides Pharma Business Overview
Table 150. Strides Pharma Recent Developments
Table 151. NextPharma Pharmaceutical CMO and CDMO Basic Information
Table 152. NextPharma Pharmaceutical CMO and CDMO Product Overview
Table 153. NextPharma Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. NextPharma Business Overview
Table 155. NextPharma Recent Developments
Table 156. Famar Pharmaceutical CMO and CDMO Basic Information
Table 157. Famar Pharmaceutical CMO and CDMO Product Overview
Table 158. Famar Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Famar Business Overview
Table 160. Famar Recent Developments
Table 161. Jubilant Pharmaceutical CMO and CDMO Basic Information
Table 162. Jubilant Pharmaceutical CMO and CDMO Product Overview
Table 163. Jubilant Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Jubilant Business Overview
Table 165. Jubilant Recent Developments
Table 166. Alcami Pharmaceutical CMO and CDMO Basic Information
Table 167. Alcami Pharmaceutical CMO and CDMO Product Overview
Table 168. Alcami Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Alcami Business Overview
Table 170. Alcami Recent Developments
Table 171. Euroapi Pharmaceutical CMO and CDMO Basic Information
Table 172. Euroapi Pharmaceutical CMO and CDMO Product Overview
Table 173. Euroapi Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 174. Euroapi Business Overview
Table 175. Euroapi Recent Developments
Table 176. Eurofins Pharmaceutical CMO and CDMO Basic Information
Table 177. Eurofins Pharmaceutical CMO and CDMO Product Overview
Table 178. Eurofins Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 179. Eurofins Business Overview
Table 180. Eurofins Recent Developments
Table 181. Avid Bioservices Pharmaceutical CMO and CDMO Basic Information
Table 182. Avid Bioservices Pharmaceutical CMO and CDMO Product Overview
Table 183. Avid Bioservices Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 184. Avid Bioservices Business Overview
Table 185. Avid Bioservices Recent Developments
Table 186. BioVectra Pharmaceutical CMO and CDMO Basic Information
Table 187. BioVectra Pharmaceutical CMO and CDMO Product Overview
Table 188. BioVectra Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 189. BioVectra Business Overview
Table 190. BioVectra Recent Developments
Table 191. CPL Pharmaceutical CMO and CDMO Basic Information
Table 192. CPL Pharmaceutical CMO and CDMO Product Overview
Table 193. CPL Pharmaceutical CMO and CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 194. CPL Business Overview
Table 195. CPL Recent Developments
Table 196. Global Pharmaceutical CMO and CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 197. Global Pharmaceutical CMO and CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 198. North America Pharmaceutical CMO and CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 199. North America Pharmaceutical CMO and CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 200. Europe Pharmaceutical CMO and CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 201. Europe Pharmaceutical CMO and CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 202. Asia Pacific Pharmaceutical CMO and CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 203. Asia Pacific Pharmaceutical CMO and CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 204. South America Pharmaceutical CMO and CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 205. South America Pharmaceutical CMO and CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 206. Middle East and Africa Pharmaceutical CMO and CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 207. Middle East and Africa Pharmaceutical CMO and CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 208. Global Pharmaceutical CMO and CDMO Sales Forecast by Type (2025-2030) & (K Units)
Table 209. Global Pharmaceutical CMO and CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 210. Global Pharmaceutical CMO and CDMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 211. Global Pharmaceutical CMO and CDMO Sales (K Units) Forecast by Application (2025-2030)
Table 212. Global Pharmaceutical CMO and CDMO Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Pharmaceutical CMO and CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmaceutical CMO and CDMO Market Size (M USD), 2019-2030
Figure 5. Global Pharmaceutical CMO and CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Pharmaceutical CMO and CDMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmaceutical CMO and CDMO Market Size by Country (M USD)
Figure 11. Pharmaceutical CMO and CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Pharmaceutical CMO and CDMO Revenue Share by Manufacturers in 2023
Figure 13. Pharmaceutical CMO and CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pharmaceutical CMO and CDMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical CMO and CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharmaceutical CMO and CDMO Market Share by Type
Figure 18. Sales Market Share of Pharmaceutical CMO and CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Pharmaceutical CMO and CDMO by Type in 2023
Figure 20. Market Size Share of Pharmaceutical CMO and CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Pharmaceutical CMO and CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharmaceutical CMO and CDMO Market Share by Application
Figure 24. Global Pharmaceutical CMO and CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Pharmaceutical CMO and CDMO Sales Market Share by Application in 2023
Figure 26. Global Pharmaceutical CMO and CDMO Market Share by Application (2019-2024)
Figure 27. Global Pharmaceutical CMO and CDMO Market Share by Application in 2023
Figure 28. Global Pharmaceutical CMO and CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pharmaceutical CMO and CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Pharmaceutical CMO and CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Pharmaceutical CMO and CDMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Pharmaceutical CMO and CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Pharmaceutical CMO and CDMO Sales Market Share by Country in 2023
Figure 37. Germany Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Pharmaceutical CMO and CDMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pharmaceutical CMO and CDMO Sales Market Share by Region in 2023
Figure 44. China Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Pharmaceutical CMO and CDMO Sales and Growth Rate (K Units)
Figure 50. South America Pharmaceutical CMO and CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Pharmaceutical CMO and CDMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pharmaceutical CMO and CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Pharmaceutical CMO and CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Pharmaceutical CMO and CDMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Pharmaceutical CMO and CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pharmaceutical CMO and CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pharmaceutical CMO and CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Pharmaceutical CMO and CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Pharmaceutical CMO and CDMO Market Share Forecast by Application (2025-2030)
Lonza
Catalent
Thermo Fisher Scientific
Samsung Biologics
Fareva
WuXi AppTech
WuXi Biologics
Siegfried
FUJIFILM Diosynth Biotechnologies
Asymchem
Pfizer CentreOne
Delpharm
Recipharm
AGC Pharma Chemicals
Boehringer Ingelheim
Vetter
Curia
Aenova
Porton
Piramal
Strides Pharma
NextPharma
Famar
Jubilant
Alcami
Euroapi
Eurofins
Avid Bioservices
BioVectra
CPL
Why Choose Us
- Extensive Library of Reports.
- Identify the clients' needs.
- Pragmatic Research Approach.
- Clarity on Market Scenarios.
- Tailor-Made Solutions.
- Expert Analysts Team.
- Competitive and Fair Prices.
Clientele
Thank you
Xcellent Insights has received your query!